0      0


2277 - Effect of Oral Nonpeptide GLP-1 Receptor Agonist Orforglipron (LY3502970) in Participants with Obesity or Overweight—A Phase 2 Study


‐ Jun 23, 2023 2:30pm


Speaker(s):

You must be logged in and own this session in order to post comments.